Corinna Lathan - 16 May 2025 Form 4 Insider Report for EKSO BIONICS HOLDINGS, INC. (EKSO)

Reporting relationship: Director
Issuer ticker: EKSO
Reported as of: 16 May 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 19 May 2025, 19:07:01 UTC
Prior SEC filing: 19 Mar 2025
Next SEC filing: 12 Feb 2026
Source filing: View source filing
Reporting owner signature: /s/ Jerome Wong, as Attorney-in-Fact

Key filing fact

Corinna Lathan filed Form 4 for EKSO BIONICS HOLDINGS, INC. (EKSO) on 19 May 2025.

Key facts

This page summarizes Corinna Lathan's Form 4 filing for EKSO BIONICS HOLDINGS, INC. (EKSO).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 19 May 2025, 19:07.

Change

Previous filing in this sequence was filed on 19 Mar 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001714701 Primary reporting owner

Lathan Corinna

Relationship: Director
Address: 101 GLACIER POINT, SUITE A, SAN RAFAEL
Signature: /s/ Jerome Wong, as Attorney-in-Fact
Signature date: 19 May 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

EKSO transaction

Common Stock

Award

Transaction value: $0
Shares: +236,202
Change %: +104%
Price: $0.000000
Shares after: 462,409
Date: 16 May 2025
Ownership: Direct
Footnotes: F1, F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Represents restricted stock units ("RSUs"). Each RSU represents the economic equivalent of one share of EKSO common stock and shall be settled in shares of EKSO common stock upon vesting.

Footnote F2

This award of RSUs was granted effective May 16, 2025, the date of the Issuer's 2025 Annual Meeting of Stockholders (the "Grant Date"), pursuant to an automatic annual non-employee director grant provision approved by the Company's Board of Directors on April 13, 2021. The RSUs are scheduled to vest and settle at the earlier of the date of the next Annual Meeting of Stockholders or the one-year anniversary of the Grant Date.

Footnote F3

Includes 236,202 unvested RSUs.